Sentences with phrase «medical diagnostic devices»

Flexible ultrahigh resolution displays have benefits for next - generation mobile electronics, such as point - of - care medical diagnostic devices.

That basic research has since yielded a torrent of industrial applications, from medical diagnostic devices to flexible electronics — more than enough to keep most scientists busy.

The new coating could be used to create durable, scratch - resistant lenses for eyeglasses, self - cleaning windows, improved solar panels, and new medical diagnostic devices, said principal investigator Joanna Aizenberg, Ph.D., who is a Core Faculty Member at the Wyss Institute, Amy Smith Berylson Professor of Materials Science at SEAS, and a Professor of Chemistry and Chemical Biology.

But the electric system remains Edison's grandest achievement: an affordable and reliable supply of electricity has opened doors to great second - order innovations ranging from medical diagnostic devices to refrigerators, from massive electrochemical industries to tiny computers governed by microchips.

«Pocket diagnosis: App turns any smartphone into a portable medical diagnostic device.»

Not exact matches

Giles & Associates Consultancy serves innovators throughout the life science and healthcare industry, including biotech, pharmaceutical, diagnostics, medical device and academic research organizations.

He cites the example of Lumed, a Mexican - Canadian startup working on ways for doctors at different sites to share images and diagnostic information from previously unconnected medical devices already in service.

Most recently, Mr. Nawana served as CEO of medical diagnostics company Alere Inc., prior to Alere, he spent 15 years at Johnson & Johnson primarily in its Medical Device & diagnostics smedical diagnostics company Alere Inc., prior to Alere, he spent 15 years at Johnson & Johnson primarily in its Medical Device & diagnostics sMedical Device & diagnostics segment.

He is a seasoned entrepreneur and business executive, having co-founded several startup companies, including Mindful Scientific, a medical device company addressing concussion diagnostics and management (winner in the Medical Device track at the 2015 HealthKick Venture Showcase); abridean (acquired by nCipher PLC), a software company developing application provisioning and identity management solutions; and i - HRx (acquired by Healthconnex), a digital health company focused on chronic disease manamedical device company addressing concussion diagnostics and management (winner in the Medical Device track at the 2015 HealthKick Venture Showcase); abridean (acquired by nCipher PLC), a software company developing application provisioning and identity management solutions; and i - HRx (acquired by Healthconnex), a digital health company focused on chronic disease managdevice company addressing concussion diagnostics and management (winner in the Medical Device track at the 2015 HealthKick Venture Showcase); abridean (acquired by nCipher PLC), a software company developing application provisioning and identity management solutions; and i - HRx (acquired by Healthconnex), a digital health company focused on chronic disease manaMedical Device track at the 2015 HealthKick Venture Showcase); abridean (acquired by nCipher PLC), a software company developing application provisioning and identity management solutions; and i - HRx (acquired by Healthconnex), a digital health company focused on chronic disease managDevice track at the 2015 HealthKick Venture Showcase); abridean (acquired by nCipher PLC), a software company developing application provisioning and identity management solutions; and i - HRx (acquired by Healthconnex), a digital health company focused on chronic disease management.

Andrew's primary responsibility at RA Capital is to evaluate public and private investments in companies developing drugs, medical devices, diagnostics, and research tools, with a focus on new company formation.

H.I.G.'s seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer.

Ysios Capital is a leading Spanish venture capital firm that provides private equity financing to early - and mid-stage human healthcare and life science companies with a special focus on pharmaceuticals, diagnostics and medical devices.

In 1996, Alexandria founded Alexandria Venture Investments to actively invest at the cutting edge of novel, breakthrough discoveries in biopharmaceuticals, diagnostics, research tools, medical devices, digital health, and technology.

We target opportunities in the Americas across various health care sub-sectors, including biopharmaceuticals, medical devices, diagnostics ⁄ life science tools, providers, HCIT ⁄ informatics, and other services.

These include Mindful Scientific, a medical device company addressing concussion diagnostics and management that won the startup competition at the Wall Street Journal WSJ.D Live global technology conference and the Medical Device track at the HealthKick Challenge; abridean (acquired by nCipher PLC), a software company that develops application provisioning and identity management solutions; and i - HRx (acquired by HealthConnex), a digital health company focused on chronic disease manamedical device company addressing concussion diagnostics and management that won the startup competition at the Wall Street Journal WSJ.D Live global technology conference and the Medical Device track at the HealthKick Challenge; abridean (acquired by nCipher PLC), a software company that develops application provisioning and identity management solutions; and i - HRx (acquired by HealthConnex), a digital health company focused on chronic disease managdevice company addressing concussion diagnostics and management that won the startup competition at the Wall Street Journal WSJ.D Live global technology conference and the Medical Device track at the HealthKick Challenge; abridean (acquired by nCipher PLC), a software company that develops application provisioning and identity management solutions; and i - HRx (acquired by HealthConnex), a digital health company focused on chronic disease manaMedical Device track at the HealthKick Challenge; abridean (acquired by nCipher PLC), a software company that develops application provisioning and identity management solutions; and i - HRx (acquired by HealthConnex), a digital health company focused on chronic disease managDevice track at the HealthKick Challenge; abridean (acquired by nCipher PLC), a software company that develops application provisioning and identity management solutions; and i - HRx (acquired by HealthConnex), a digital health company focused on chronic disease management.

Robert Mittendorff, MD, MBA, Partner, Norwest Venture Partners Robert focuses on investing capital in venture and growth opportunities in the healthcare sector, including digital health and healthcare IT, technology enabled healthcare services, medical devices, diagnostics, and specialty pharma.

He brings extensive operating knowledge to Norwest Venture Partners, where he focuses on mid-to-late-stage investments in consumer and digital health, healthcare IT, medical devices and diagnostics, technology - enabled healthcare services, and specialty pharmaceuticals.

MH Scholla, «The Effects of Radiation Sterilization on the Microbial Barrier Properties of Tyvek,» Medical Device & Diagnostic Industry 21, no. 10 (1999): 120 — 126.

About one in five of them worked in manufacturing, where they develop diagnostic instruments, implantable devices, and medical informatics and imaging systems.

The recent growth is driven, experts say, by aging populations and increased life expectancy in the developed world; combination products that couple a medical device with a drug, the device usually acting as a drug - delivery vehicle; miniaturization (via nanotechnology), making medical devices less invasive; and the use of molecular diagnostics to customize therapeutic regimens and to assess individual disease risk.

Medical devices range from the simple, such as Band - Aids, to the high - tech, such as imaging machines and the BRCA1 and BRCA2 molecular diagnostic tests for breast cancer (see sidebar).

The U.S. Food and Drug Administration (FDA) classifies medical devices and diagnostic tests as Class I, II, or III.

These days, Fisher prefers the challenge and variety of working as a consultant in the area of the profession known as diagnostic medical physics, evaluating and certifying the safety and accuracy of devices including MRI, CAT, and bone density scanners; mammography machines; and more.

«The medical device and diagnostics business is one of the best kept secrets of the life sciences industry,» says Tom Ippolito, Ph.D., vice president of regulatory affairs and quality assurance at Chembio, a Medford, New York — based medical device and molecular diagnostics manufacturer.

«Another application could include implantable miniature diagnostic medical devices, wirelessly powered from a source external to the body.

The new technology may prove useful in medical diagnostic or other devices where tiny streams of fluid could be turned on or off by switching the surface behavior of a material.

Such a device could be used in homeland security applications to detect volatile chemicals and in medical diagnostics, such as a device to test blood - alcohol level.

In patients with non-conditional devices who have a medical need for imaging, and in whom MRI is deemed the most desirable diagnostic tool, MRI usually hasn't been used, or the non-conditional devices and leads have been removed and replaced with conditional devices and leads beforehand.

«However, while they aren't designed as medical devices — when smartphones and apps begin to be used clinically — it is important that they are evaluated in the same rigorous manner by which we assess all therapies and diagnostic tests,» says lead author Dr. Pietro Di Santo.

The microfluidic device designed by his team captures cells based on their distinct internal structure — a mechanical analysis instead of the blood chemistry analysis used in conventional medical diagnostic techniques.

The kits will enable doctors and medical students to devise diagnostics, drug delivery devices, microfluidic chips, and more.

The MTRAC for Life Sciences Innovation Hub, co-managed by the U-M Medical School's Fast Forward Medical Innovation and the U-M Office of Technology Transfer, is a statewide program that supports translational research projects in life sciences — including medical devices, diagnostics, therapeutics, and health - related information technology — with high commercial potMedical School's Fast Forward Medical Innovation and the U-M Office of Technology Transfer, is a statewide program that supports translational research projects in life sciences — including medical devices, diagnostics, therapeutics, and health - related information technology — with high commercial potMedical Innovation and the U-M Office of Technology Transfer, is a statewide program that supports translational research projects in life sciences — including medical devices, diagnostics, therapeutics, and health - related information technology — with high commercial potmedical devices, diagnostics, therapeutics, and health - related information technology — with high commercial potential.

These include life science industry representatives from pharmaceutical, medical devices and diagnostic industries, clinical innovators, hospital executives, payers, policy makers, multidisciplinary researchers, patient advocates, angel, venture capital investors and academia.

Its 680 members include companies, research institutions and universities, government groups and corporate service providers involved in biotechnology, pharmaceuticals, medical devices and diagnostics, medical informatics and related businesses.

We use the power of DNA self - assembly to build and test nanophotonic devices such as plasmonic waveguides for application in optical near - field communication, or for medical diagnostics and therapeutics.

New diagnostic imaging, surgical tools and therapeutic implants are examples of what the U.S. Food & Drug Administration defines as medical devices.

Vancouver, British Columbia About Blog NanoApps Medical Inc. investigates and develops advanced, innovative, and cost effective nanomedical diagnostic and therapeutic devices and systems.

The paragraph you quoted goes on to include «legal medical services» as well as «costs» of equipment, supplies, diagnostic devices, transportation, and even insurance.

The only other rationale I come up with is that diagnostics / medical device businesses can potentially offer dramatically higher margins to an acquirer.

JNJ has an amazing set of products in various segments: baby care, skin & hair care, wound care & topicals, oral heath care, OTC medicines like tylenol, motrin, benadryl, etc., nutritionals, vision care, medical devices and diagnostic products, prescription pharmaceutical products, that are used daily by millions world over.

A veterinary clinical trial is a study conducted on veterinary patients and focused on evaluating the effects of new therapies, medical devices and diagnostic tests for eventual use in veterinary or human medicine.

These products and services include medicines and vaccines, diagnostics, medical devices, pet supplies, nutritional supplements, veterinary and other related services.

Mr. Stellabotte has worked on matters involving a broad range of technologies, including computer hardware and software, consumer electronics, telecommunications products and services, smart phones, tablets, and mobile media technologies, data transmission, Internet, digital video compression standards, CDs and DVDs, mobile phones, the ATSC digital television standard, navigation and location - based services, pharmaceutical capsules, biotechnology, including immunoassays, home pregnancy and other diagnostic tests, and medical devices, financial services, e-commerce, pharmaceuticals, and food products and processes.

Draft compliance policies for genetic testing and laboratory services pharmaceutical, biotech, medical device and diagnostic testing companies.

He has significant experience with respect to transactions related to small molecule pharmaceuticals, biologics, cellular therapies, gene therapy, diagnostics and medical devices, both within the United States as well as in other major markets such as Europe, Asia and South America.

In the field of life sciences, he has successfully litigated major cases involving recombinant DNA, monoclonal antibodies, fusion proteins, siRNAs, small molecule compounds, drug delivery, molecular diagnostics, research tool patents, and medical devices.

For many years, Davis Polk has been advising clients — ranging from the world's largest healthcare companies to startups — with a focus on pharmaceuticals, biotechnology, diagnostics, medical devices and healthcare equipment, genetics, and other areas.

CRA's life sciences litigation support is grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets.

Preparation and global prosecution of patent applications directed to diagnostic and therapeutic products including antibodies, gene therapies, vaccines, stem cells, pharmaceutical formulations, nanotechnology, nucleic acid molecules, biologics, medical devices, mouse platforms for antibody development, and methods of treating diseases.

Our clients range from medical device and pharmaceutical manufacturers to companies focusing on diagnostic testing, biologics, biosimilars and small molecules, among other areas of the life sciences industry.